louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT03151213: Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
Official title: Effect of Preoperative Administration of Oral Pregabalin on the Postoperative Analgesia in Patients Scheduled for Radiofrequency Ablationof Focal Lesions in the Liver
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Hepatocellular Cancer
Lead sponsor: Tanta University
Sponsor class: OTHER
First posted: 2017-05-12
Enrollment: 100
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.

Detailed description: Our data will investigate if preemptive administration of pregabalin will have a role in reducing postoperative pain after radiofrequency ablation (RFA) of liver cancer.

Eligibility criteria: Inclusion Criteria:

* HCC patients, Child A, B, scheduled for Radiofrequency ablation of HCC.

Exclusion Criteria:

* Encephalopathy, Renal impairment

Primary outcomes:
measure: visual analogue pain scale (VAS Pain) post operatively
timeFrame: 2 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Tanta university - faculty of medicine
state: Elgharbia
Study officials:
affiliation: Tanta University Faculty of Medicine
name: Amr Magdy Abdelfattah, consultant
role: PRINCIPAL_INVESTIGATOR
affiliation: Tanta university Faculty of Medicine
name: Sherief Abd-Elsalam, Consultant
role: STUDY_DIRECTOR
References:
Clinical trial NCT06852313: Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
Official title: Save the Ovaries - Surgical Management of Simple Ovarian Cysts in Children and Adolescents
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Ovarian Cyst Benign
Keywords: Ovarian cyst
Laparoscopy
Child
Lead sponsor: University Children's Hospital, Zurich
Sponsor class: OTHER
Collaborators: name: University Children's Hospital Basel
First posted: 2025-02-28
Enrollment: 80
Sex: FEMALE
Minimum age (years): 1
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to evaluate which operative technique should be used for managing simple ovarian cysts in girls and adolescents. The two techniques that are being compared are laparoscopic cyst enucleation and laparoscopic cyst deroofing. The investigators will assess the effect of both techniques on the ovarian reserve and the risk of cyst recurrence.


Eligibility criteria: Inclusion Criteria:

* Symptomatic simple cysts ≥ 4 cm with indication for surgical intervention
* Asymptomatic cysts ≥ 4 cm, with surgical indication due to persistence or increase in size
* Asymptomatic cysts ≥ 4 cm with other pathology as surgical indication, if known preoperatively
* Age 12 months - 18 years
* Parents/legal custodian and patient give consent, for patients unable to consent due to their health condition or developmental status they show no signs of unwillingness to participate
* Symptomatic simple cysts ≥ 4 cm with indication for surgical intervention on both ovaries (each ovary will count as one)

Exclusion Criteria:

* Neonatal ovarian cysts (age \<12 months)
* Age \>18 years
* Complex cysts (with solid components, e.g., Teratoma, risk or suspicion of malignancy)
* Paratubar/paraovarian cysts
* Medical reason that precludes cyst enucleation (e.g. severe coagulopathy)
* Neither signed informed consent form or inadequate german, french or english language skills to give informed consent

Primary outcomes:
measure: Postoperative change of AMH level
timeFrame: 8 weeks
Secondary outcomes:
measure: Postoperative recurrence rate
timeFrame: 14 weeks
Other outcomes:
measure: Intraoperative complications
timeFrame: 2 weeks
measure: Operative times
timeFrame: 2 weeks
measure: Postoperative ipsilateral ovarian volume on ultrasound
timeFrame: 14 weeks
measure: Postoperative adnexal ratio
timeFrame: 14 weeks
measure: Postoperative histology
timeFrame: 8 weeks
measure: Postoperative microscopic follicle count
timeFrame: 14 weeks
measure: Postoperative complications
timeFrame: 14 weeks
Locations:
city: Basel
country: Switzerland
facility: University Children's Hospital Basel
city: Zurich
country: Switzerland
facility: University Children's Hospital Zurich
Study officials:
References:
Clinical trial NCT02028013: Management of Sexual Dysfunction With Bioresonance Technique
Official title: Management of Male Sexual Dysfunction With Bioresonance Technique, a New Egyptian Device
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Sexual Dysfunction
Erectile Dysfunction
Premature Ejaculation
Keywords: Erectile dysfunction, sexual dysfunction, bioresonance
Lead sponsor: Man Clinic for Andrology, Male Infertility and Sexual Dysfunction
Sponsor class: OTHER
First posted: 2014-01-06
Enrollment: 600
Sex: MALE
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients complaining from erectile dysfunction

Brief summary: Bioresonance is the big promise of the medical technology of the future because it stimulates the self-regenerating system of the body by affecting the body's most essential procedures. The big advantage is that its multiple and there are no harmful side effects. This therapy teaches something to the body what in a younger and healthier state it had already Bioresonance is based on the scientific principle that metabolism within cells is influenced by one's electromagnetic field.

We start to use bioresonance technology in management of erectile dysfunction , premature ejaculation, decreased libido.


Eligibility criteria: Inclusion Criteria:

* erectile dysfunction Premature ejaculation Decreased libido

Exclusion Criteria:

* nil

Primary outcomes:
measure: Patient satisfaction
timeFrame: 2-6 months
Secondary outcomes:
measure: Penile duplex study
timeFrame: 2 months
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: Man Clinic
Study officials:
affiliation: AlAzhar university , Man clinic
name: Khaled A Gadalla, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02908113: Visual Perception in Preterm Infants
Official title: Sensory Maturation of Preterm Infants: From Visual Sensitivity to Multisensory Perception
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Pediatrics
Lead sponsor: University Hospital, Strasbourg, France
Sponsor class: OTHER
First posted: 2016-09-20
Enrollment: 150
Sex: ALL
Minimum age (years): 23
Maximum age (years): 42
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: We aim to increase our knowledge of the impact of preterm birth on the maturation of the visual and auditory systems and on the development of multisensory perception

Specifically, we aim to evaluate the preterm infants' capabilities of detection and discrimination of different visual and auditory stimuli according to gestational age, post menstrual age and the duration of the postnatal life.

A secondary aim is to compare this competencies in preterm and full term control art term equivalent age.

The final aim is to optimize the hospital environment in order to make it correspond to the expectations and sensory abilities of very preterm infants.

Our hypothesis is that preterm birth exposes the infants to numerous atypical stimuli which could accelerate the processes of sensory maturation


Eligibility criteria: Inclusion Criteria:

* Newborn less than 32 weeks PMA hospitalized in the Hospital of Hautepierre, Strasbourg, France)
* Consent obtained from both parents
* Social insurance coverage

Exclusion Criteria:

* Any known malformation
* Brain lesions discovered on brain ultrasound (Intra-Ventricular hemorrhage grade III or IV periventricular Leukomalacia).
* Unstable clinical State
* Retinopathy Of Prematurity stage\> 2 or in zone 1
* Family history of abnormal color vision.
* Abnormalities in auditory testing
* Transfer to another hospital expected before 40 week PMA

Primary outcomes:
measure: visual stimulus detection with luminance
timeFrame: 3 months
measure: auditory stimulus detection with parents voice
timeFrame: 3 months
Secondary outcomes:
measure: behavioral responsiveness to visual stimuli calibrated collected from video recordings
timeFrame: 3 months
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Les Hôiptaux Universitaires
Study officials:
affiliation: Les Hôpitaux Universitaires de Strasbourg
name: Claire KOENIG ZORES, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03919513: Effect of Combined IMT and CPAP in Pulmonary Rehabilitation for COPD
Official title: Effect of Combined Inspiratory Muscle Training and Continuous Positive Airway Pressure in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pulmonary Rehabilitation
Keywords: IMT,NPPV,Pulmonary rehabilitation
Lead sponsor: Zhujiang Hospital
Sponsor class: OTHER
First posted: 2019-04-18
Enrollment: 30
Sex: ALL
Minimum age (years): 40
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: Inspiratory muscle training(IMT) was one of the widely used pulmonary rehabilitation method in COPD patients.However, when the respiratory muscles are fatigue without sufficient rest, IMT may increase muscle fatigue and aggravate muscle damage. Noninvasive positive pressure ventilation (NPPV) is another important strategy of pulmonary rehabilitation which could overcome airway resistance and reduce respiratory work, improve respiratory muscle fatigue. Therefore, the purpose of this study was to explore the effective of the "IMT - NPPV sequential" rehabilitation method, that is, first inspiratory muscle training, followed by respiratory muscle resting (non-invasive positive pressure ventilation).

Detailed description: Exploring the effects of the new rehabilitation method of "IMT - NPPV sequential", comparing with the single rehabilitation strategy such as inspiratory muscle training and non-invasive positive pressure ventilation.

Eligibility criteria: Inclusion Criteria:

* Patients with pulmonary function test of forced expiratory volume at one second (FEV1)/forced vital capacity(FVC) \< 70% after inhalation of bronchial dilation agent. Patients in a clinically stable state.

Exclusion Criteria:

* Patients were excluded if they had other respiratory diseases ,or evidence of pneumothorax or mediastinal emphysema and pacemaker installed.

Patients with acute cardiovascular event and severe cor pulmonale. Patients with poor compliance. An Other causes of diaphragmatic dysfunction

Primary outcomes:
measure: Respiratory muscle strength(composite outcome measure)
timeFrame: Change from baseline to 8 weeks
Secondary outcomes:
measure: Diaphragmatic function
timeFrame: Change from baseline to 8 weeks
measure: Symptom Evaluation(composite outcome measure)
timeFrame: Change from baseline to 8 weeks
measure: Pulmonary function(composite outcome measure)
timeFrame: Change from baseline to 8 weeks
measure: Exercise capacity
timeFrame: Change from baseline to 8 weeks
Other outcomes:
Locations:
city: Guangzhou
country: China
facility: Zhujiang Hospital,Southern Medical Universicity
state: Guangdong
Study officials:
affiliation: Zhujiang Hospital,Southern Medical Unversity
name: Chen Xin, Doctor
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06267313: Attention Training for COVID-19 Related Distress
Official title: Attention Training for COVID-19 Related Distress
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Anxiety
Lead sponsor: Palo Alto University
Sponsor class: OTHER
First posted: 2024-02-20
Enrollment: 6
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.


Eligibility criteria: Inclusion Criteria:

* COVID-19 Anxiety Syndrome Scale \> 7 and/or COVID-19 related loss

Exclusion Criteria:

* Does not speak English Fluently

Primary outcomes:
measure: COVID-19 Anxiety Syndrome Scale
timeFrame: 0 days
measure: COVID-19 Anxiety Syndrome Scale
timeFrame: 21 days
measure: COVID-19 Anxiety Syndrome Scale
timeFrame: 49 days
measure: COVID-19 Anxiety Syndrome Scale
timeFrame: 105 days
Secondary outcomes:
Other outcomes:
Locations:
city: Palo Alto
country: United States
facility: Palo Alto University
state: California
Study officials:
References:
Clinical trial NCT04539613: Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle
Official title: Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Ovarian Stimulation in ICSI
Lead sponsor: Minia University
Sponsor class: OTHER
First posted: 2020-09-07
Enrollment: 100
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 35
Standard ages: ADULT
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Normal ovulatory function and normal semen analysis

Brief summary: despite the large number of papers published on COH protocols comparing the efficiency of different exogenous gonadotropins, no confirmed protocol exists, and it is not quite clear which is superior to the others.

Detailed description: , the objective of the current study was to compare the efficacy of 2 different ovarian stimulation protocols, comprising hpFSH, HMG versus R-FSH on oocyte and embryo quality and IVF treatment outcome in patients undergoing IVF or intracytoplasmic sperm injection (ICSI)(4).

Eligibility criteria: Inclusion Criteria:

* 1-Aged 20-35 yr, male factor, 2-Tubal or unexplained infertility, 3-regular menstruation cycle between 21 and 35 days, 4-Normal function of uterus according to hysterosalpingography, hysteroscopy or transvaginal ultrasonography, 5-Normal ovaries according to transvaginal ultrasonography during past 6 months prior to study and compatible with normal adnexa and 6-Normal ovarian anatomy, and serum FSH level less than 8 IU/l All women showed no recognizable endometriosis according to symptoms and clinical examination in transvaginal ultrasonography or diagnostic laparoscopy. 7-7-All women have a history of unexplained infertility 8-Normal ovulatory function and normal semen analysis according to the World Health Organization criteria .

Exclusion Criteria:

* Patients with other ovulation disorders such as hypo and hypergonadotropic, hypogonadism, hyperprolactinemia.

  2-Thyroid disorders. 3-Ovarian or adrenal neoplasms. 4-Cushing syndrome. 5-previous history of systemic diseases such as endocrine and metabolic disorders.

  6- Previous history of inappropriate ovarian response to stimulation with gonadotropins (poor responders).

  7-Prior history of more than 3 unsucce

Primary outcomes:
measure: fertility outcomes (pregnancy rate, abortion and live birth rate) in IVF patients.
timeFrame: 5months
Secondary outcomes:
Other outcomes:
Locations:
city: Minya
country: Egypt
facility: El neel
Study officials:
References:
citation: Kamel RM. The onset of human parturition. Arch Gynecol Obstet. 2010 Jun;281(6):975-82. doi: 10.1007/s00404-010-1365-9. Epub 2010 Feb 3.
Clinical trial NCT01892813: Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
Official title: Tailored Tobacco Intervention
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE3
Conditions: Nicotine Dependence
Tobacco Use
Keywords: Nicotine dependence
Smoking cessation
Telehealth
Alcohol use
Depression
Body weight
Lead sponsor: University of Iowa
Sponsor class: OTHER
Collaborators: name: VA Office of Research and Development
First posted: 2013-07-04
Enrollment: 411
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.


Eligibility criteria: Inclusion Criteria:

* Veteran status
* 18 + years of age
* Smoke cigarettes on at least a daily basis
* Receive primary care from the Iowa City VA Health Care System or an affiliated Community-based Outpatient Clinic (CBOC)
* Live in a non-metropolitan area (based on Rural-Urban Commuting Area Codes (RUCA) codes)
* Be willing to make an attempt to quit smoking in the next 30 days
* Be capable of providing informed consent
* Have access to a telephone (land line or cell phone)
* Have a stable residence

Exclusion Criteria:

* Planning to move within the next 12 months
* Presence of a terminal illness
* Pregnancy
* Unstable psychiatric disorder (e.g., acute psychosis)
* Currently pregnant
* Incarcerated
* Institutionalized

Primary outcomes:
measure: Tobacco use
timeFrame: Six-month follow-up
Secondary outcomes:
measure: Alcohol use
timeFrame: Six-month follow-up
measure: Depressive symptoms
timeFrame: Six-month follow-up
measure: Body weight
timeFrame: Six-month follow-up
measure: Physical Activity
timeFrame: Six-month follow-up
measure: Dietary intake
timeFrame: Six-month follow-up
Other outcomes:
Locations:
city: Iowa City
country: United States
facility: Iowa City VA Healthcare System
state: Iowa
Study officials:
affiliation: VRHRC-CR
name: Mark W. Vander Weg, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03196713: Early Intervention, Supervision, Quality and Outcome in ASD
Official title: Quality and Efficacy of Early Intensive Autism Intervention: a Matter of Trust, Knowledge, and Supervision?
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Autism Spectrum Disorder
Keywords: Allegiance
Knowledge
Supervision
Early intervention
Autism
Lead sponsor: Karolinska Institutet
Sponsor class: OTHER
First posted: 2017-06-23
Enrollment: 34
Sex: ALL
Minimum age (years): 2
Maximum age (years): 6
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Pragmatic RCT
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The objective of this study is to examine the significance of knowledge of autism spectrum disorder (ASD), and early intensive behavioral intervention, as well as trust in EIBI, adequate assessment of EIBI quality, and EIBI supervision on EIBI intervention outcome in ASD.


Eligibility criteria: Inclusion Criteria:

* Diagnosis of ASD (ICD-10), ongoing EIBI program

Exclusion Criteria:

-

Primary outcomes:
measure: York Measure of Quality of Behavioural Intensive Intervention (YMQI)
timeFrame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
Secondary outcomes:
measure: Vineland Adaptive Behavior Scales (VABS)
timeFrame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
measure: Social Responsiveness Scale (SRS)
timeFrame: Change is assessed from baseline (probe 1) to probe 2 (2-3 months), and probe 3 (4-6 months)
Other outcomes:
Locations:
city: Stockholm
country: Sweden
facility: KIND, CAP Research Center
Study officials:
affiliation: Karolinska Institutet, KBH, KIND
name: Sven Bolte, Prof, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Langh U, Cauvet E, Hammar M, Bolte S. Cross-Cultural Validation of the York Measure of Quality of Intensive Behavioral Intervention. Behav Modif. 2017 Nov;41(6):808-828. doi: 10.1177/0145445517719397. Epub 2017 Jul 9.
citation: Langh U, Hammar M, Klintwall L, Bolte S. Allegiance and knowledge levels of professionals working with early intensive behavioural intervention in autism. Early Interv Psychiatry. 2017 Oct;11(5):444-450. doi: 10.1111/eip.12335. Epub 2016 Apr 6.
Clinical trial NCT02704013: Urinary Biomarkers in Overactive Bladder in Children
Official title: Role of Urinary Neurotrophin and Cytokine Levels in Diagnosis and Management of Overactive Bladder in Children
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Overactive Bladder
Keywords: Neurotrophins
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Urinary Biomarkers
Urodynamics
Anticholinergics
Children
Lead sponsor: Children's Hospital Zagreb
Sponsor class: OTHER
Collaborators: name: University Hospital for Infectious Diseases, Croatia
First posted: 2016-03-09
Enrollment: 50
Sex: ALL
Minimum age (years): 3
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: DIAGNOSTIC

Brief summary: It is a single-center, prospective, interventional, single-arm study. Aim is to investigate which variables are significantly correlated with prolonged anticholinergic treatment (\>6 months) in children with overactive bladder (OAB). Investigated variables will include urinary neurotrophins and inflammatory cytokines, sonographic biomarkers, symptom score scale, demographics, and urodynamic findings. Secondary aim is to analyze sensitivity and specificity of urinary biomarkers in diagnosis and management of OAB compared to urodynamics and treatment outcome.


Eligibility criteria: Inclusion Criteria:

* urgency with or without frequency, incontinence, enuresis, or nocturia
* an unremarkable clinical examination
* a minimum of 3 micturitions per day
* informed oral and written consent from the child and both parents/legal guardian

Exclusion Criteria:

* acute urinary tract infection
* diseases of central or peripheral nerve system
* anomalies of lumbosacral region
* bladder outlet obstruction
* operative procedures or anomalies of urinary or genital tract
* hypercalcuria, diabetes mellitus, diabetes insipidus
* neurogenic bladder
* constipation or fecal incontinence
* urolithiasis, depression, eating disorders or cardio-metabolic diseases
* prior use of anticholinergic treatment during the last year

Primary outcomes:
measure: Initial success
timeFrame: 6 months after start of intervention
Secondary outcomes:
measure: Long-term success
timeFrame: 6 months after stop of intervention
measure: Bladder wall thickness
timeFrame: 6 months after start of intervention
measure: Improvement in health-related quality of life measured by PedsQL 4.0 Generic Core questionnaire
timeFrame: 6 months after start of intervention
measure: Urinary neurotrophins
timeFrame: 6 months after start of intervention
measure: Urinary cytokines
timeFrame: 6 months after start of intervention
measure: Urodynamics
timeFrame: 6 months after start of intervention
Other outcomes:
Locations:
city: Zagreb
country: Croatia
facility: Children's Hospital Zagreb
Study officials:
affiliation: Children's Hospital Zagreb
name: Slaven Abdovic, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References: